Trial Profile
Dermato-pharmacokinetic study of single application of lanoconazole
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Mar 2020
Price :
$35
*
At a glance
- Drugs Lanoconazole (Primary)
- Indications Candidiasis; Seborrhoeic dermatitis; Tinea; Tinea cruris; Tinea pedis
- Focus Pharmacokinetics
- 25 Mar 2020 Status changed from not yet recruiting to completed.
- 05 Oct 2017 New trial record